Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Heparin sodium (inhalation use)

EU orphan designation number: EU/3/05/337
Active ingredient: Heparin sodium (inhalation use)
Indication: Treatment of cystic fibrosis
Sponsor: Vectura Group plc
1 Prospect West, Chippenham, Wiltshire SN14 6FH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/01/2006 Centralised Orphan - Designation EMEA/OD/054/05 (2005)5976 of 23/12/2005
13/01/2014 Centralised Orphan - Removal of orphan designation from Community Register